IMPL
Impel Pharmaceuticals Inc. Common Stock
IMPL
IMPL
Delisted
IMPL was delisted on the 15th of December, 2023.
35 hedge funds and large institutions have $99.6M invested in Impel Pharmaceuticals Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
35
Holders Change
-4
Holders Change %
-10.26%
% of All Funds
0.56%
Holding in Top 10
4
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+100%
% of All Funds
0.06%
New
6
Increased
6
Reduced
10
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
JGC
1
J. Goldman & Co
New York
|
$751K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$187K |
| 3 |
RJA
3
Raymond James & Associates
St Petersburg,
Florida
|
$54.4K |
| 4 |
4
Jane Street
New York
|
$49.3K |
| 5 |
MP
5
McDonald Partners
Cleveland,
Ohio
|
$43.9K |
